Rare disease research sits at one of the most complex intersections in healthcare: limited patient populations, highly specialized knowledge, and critical decisions that often directly impact lives.
But behind every successful study is a less visible yet often underestimated challenge: recruiting the right medical professionals.
At OnTarget, we’ve learned that when it comes to rare disease research, recruitment is not just an operational step. It is a strategic pillar that directly impacts data quality, timelines, and ultimately, the reliability of insights.

Why Rare Disease Research Is Different
Rare diseases involve small and highly specific populations. This creates a ripple effect across the entire research process:
- Fewer eligible participants
- Highly specialized physicians
- Strong reliance on trusted networks
- Greater sensitivity around participation
When physicians are involved, the complexity increases even further.
The Reality of Recruiting Physicians
Physicians are not a typical audience. They are highly trained professionals with years of specialization, demanding schedules, and selective use of their time.
They are also cautious when engaging with research, especially in sensitive areas like rare diseases.
Recruitment in this context requires precision, respect, and strong relationship-building.
The Hidden Layer: Access Is Not Direct
Access to physicians is rarely direct.
In many cases, the first interaction is with an assistant or gatekeeper. This creates a dual relationship dynamic:
- Building trust with the assistant
- Earning the physician’s attention and confidence
Without mastering this dynamic, even well-designed studies can fail.
Reputation Travels Fast
In the medical community, reputation is everything.
Physicians share experiences and remember how they were approached.
- A respectful interaction builds credibility
- A poor experience can impact access across an entire network
In rare disease research, trust is foundational.
Timing Is Strategy
Reaching physicians requires precision.
- Contact must happen at the right moments
- Communication needs to be tailored
- Follow-ups require sensitivity
This is not about volume. It is about accuracy.
Local Knowledge Makes the Difference
Healthcare systems vary across regions:
- Public and private dynamics
- Access pathways
- Institutional structures
Without local understanding, recruitment becomes inefficient.
Incentives Are Not Enough
Compensation matters, but it is not the main driver.
Physicians engage when there is:
- Relevance
- Trust
- Professional interest
- Confidence in the process
There is also natural skepticism toward industry-sponsored research.

Recruitment Is About Relationships
Successful rare disease studies are built on:
- Long-term relationships
- Consistent communication
- Trust and reliability
The OnTarget Approach
OnTarget replaces fragmented recruitment models with a dedicated internal team.
This ensures:
- Consistency in communication
- Strong participant relationships
- Alignment with client expectations
- Higher success in complex recruitments
Why Recruitment Defines the Outcome
Rare disease research requires more than operational excellence. It demands a structured, relationship-driven approach to physician engagement.
The quality of recruitment directly defines the quality of the data, the feasibility of timelines, and the credibility of the final insights.
At OnTarget, this is approached as a controlled and deliberate process. From the initial feasibility assessment to participant validation, every step is designed to ensure alignment between study objectives, physician profiles, and local market realities.
This includes understanding access dynamics, working through trusted networks, and maintaining consistent, respectful communication throughout the entire engagement. Each interaction is managed with precision, not only to secure participation but to protect the integrity of the relationship and the study itself.
In this context, recruiting the right physicians is not a step in the process.
It is a critical success factor that shapes the outcome of the entire study.